Grant of Options & PDMR Dealing

RNS Number : 7234T
CVS Group plc
26 November 2021
 

 

 

26 November 2021

CVS Group plc

("CVS", the "Company" and, together with its subsidiaries, the "Group")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing 

CVS Group plc (the "Company") announces that as part of its 2021/2022 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman  310 SAYE scheme options

Robin Alfonso  291 SAYE scheme options

Ben Jacklin    310 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,974 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2021, being the invitation date.

 

In response to accepted invitations, a total of 215,022 SAYE Scheme options over Ordinary Shares were granted on 25 November 2021, equating to 0.30% of the current issued ordinary share capital.  Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2025. 

 

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

 

 

 

CVS Group plc

via MHP Communications

Richard Fairman, CEO

 

Jenny Farrer, Company Secretary

 

 

 

Singer Capital Markets (Nominated Adviser & Broker) 

+44 20 7496 3000

Aubrey Powell / Jen Boorer / Rachel Hayes

 

 

 

MHP Communications (Financial PR)

+44 20 3128 8549

Andrew Jaques / Rachel Mann / Charles Hirst

 

     

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Detailsofthepersondischargingmanagerialresponsibilities/personclosely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Detailsoftheissuer,emissionallowancemarketparticipant,auctionplatform, auctioneer or auctionmonitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Detailsofthetransaction(s):sectiontoberepeatedfor(i)eachtypeofinstrument;(ii) eachtypeoftransaction;(iii)eachdate;and(iv)eachplacewheretransactionshave beenconducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p


310

 

 

 

d)

Aggregatedinformation

 

- Aggregatedvolume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

1

Detailsofthepersondischargingmanagerialresponsibilities/personclosely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Detailsoftheissuer,emissionallowancemarketparticipant,auctionplatform, auctioneer or auctionmonitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Detailsofthetransaction(s):sectiontoberepeatedfor(i)eachtypeofinstrument;(ii) eachtypeoftransaction;(iii)eachdate;and(iv)eachplacewheretransactionshave beenconducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p


291

 

 

 

d)

Aggregatedinformation

 

- Aggregatedvolume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

1

Detailsofthepersondischargingmanagerialresponsibilities/personclosely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Detailsoftheissuer,emissionallowancemarketparticipant,auctionplatform, auctioneer or auctionmonitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Detailsofthetransaction(s):sectiontoberepeatedfor(i)eachtypeofinstrument;(ii) eachtypeoftransaction;(iii)eachdate;and(iv)eachplacewheretransactionshave beenconducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p


310

 

 

 

d)

Aggregatedinformation

 

- Aggregatedvolume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIBDBDBDDGBL

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings